MOTS-c attenuates cardiac dysfunction following high altitude exposure by promoting mitophagy
Zihang Feng, Yuan Xing, Jing Lou, Han Li, Ziang Zhang, Min Li, Qing Zhu, Yang Cui, Jia Li, Feng Gao, Wei Yi, Yang Sun, Xing Zhang
Journal:FREE RADICAL BIOLOGY AND MEDICINE
IF:8.2
DOI:10.1016/j.freeradbiomed.2026.01.064
PMID:41654147
Published:2026-02-05
research field:线粒体生物学心脏病学低氧研究分子医学
Abstract
Prolonged exposure to high altitude (HA) results in a range of systemic changes, some of which, specifically for the heart, particularly cardiac changes, remain difficult to reverse after returning to low altitude. Cardiac de-acclimatization after HA exposure and its underlying mechanisms remain unclear. In this study, mice were subjected to a decompression chamber to simulate a 6000-m altitude exposure for 10 days, followed by the other 10-day de-acclimatization period at a lower altitude of 400 m. The cardiac dysfunction induced by HA exposure persisted throughout the de-acclimatization, accompanied with sustained mitochondrial dysfunction and the short peptide mitochondrial open reading frame of the 12S ribosomal RNA type-c (MOTS-c) deficiency. Exogenous supplementation of MOTS-c during de-acclimatization effectively alleviated the cardiac dysfunction post HA exposure. Mechanistically, MOTS-c activated the PTEN-induced putative kinase 1 (Pink1) / Parkin pathway, promoting mitophagy and improving mitochondrial quality. Silencing Pink1 abolished the protective effects of MOTS-c during de-acclimatization. Additionally, reduced circulating MOTS-c levels were observed in patients with high altitude heart disease and acute coronary syndrome. These results suggest that HA exposure leaves a memory of cardiac dysfunction upon return to lower altitude. This is attributed to a sustained deficiency in MOTS-c. MOTS-c maintains mitochondrial quality through promoting mitophagy, highlighting its therapeutic potential for treating HA-induced cardiac dysfunction during de-acclimatization.
本文使用的Yeasen产品


